Phase 2 Pulmonary Arterial Hypertension (PAH) trials recruiting now

All Pulmonary Arterial Hypertension (PAH) trials, every phase

Other phases for Pulmonary Arterial Hypertension (PAH)

Phase 2 Pulmonary Arterial Hypertension (PAH) trials

• A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
  NCT07593027 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 29 locations
• A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
  NCT07175038 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 23 locations
• Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
  NCT07318597 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.